US SB1140 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Introduced on April 11 2019 - 25% progression, died in committee
Action: 2019-04-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 11 2019 - 25% progression, died in committee
Action: 2019-04-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Excludes biological products that were initially licensed under the Federal Food, Drug, and Cosmetic Act (FD&C Act) (e.g., insulin) from the exclusivity protections that delay the licensure of biosimilar products under the Public Health Service Act (PHS Act). (The Biologics Price Competition and Innovation Act of 2009 generally requires that biological products approved under the FD&C Act are treated as though they were approved under the PHS Act through March 23, 2020.)
Title
Protecting Access to Biosimilars Act of 2019
Sponsors
| Sen. Tina Smith [D-MN] | Sen. Bill Cassidy [R-LA] | Sen. Kevin Cramer [R-ND] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-04-11 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB2011 (Related) 2019-04-02 - Referred to the Subcommittee on Health.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
SB1895 (Related) 2019-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 133.
Subjects
Allergies
Blood and blood diseases
Drug safety, medical device, and laboratory regulation
Health
Health promotion and preventive care
Health technology, devices, supplies
Immunology and vaccination
Licensing and registrations
Blood and blood diseases
Drug safety, medical device, and laboratory regulation
Health
Health promotion and preventive care
Health technology, devices, supplies
Immunology and vaccination
Licensing and registrations
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1140/all-info |
| Text | https://www.congress.gov/116/bills/s1140/BILLS-116s1140is.pdf |
